Different types of epithelial cadherin alterations play different roles in human carcinogenesis

Advances in Anatomic Pathology

Volumn 9, Issue 6, 2002, Pages 329-337

  Sobrinho Simões, Manuel ^a,b   Oliveira, Carla ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Adenocarcinoma; E cadherin; Gastric carcinoma; Inherited cancer syndrome; Isolated cell (diffuse) carcinoma; Mixed carcinoma; Prophylactic surgery

Indexed keywords

CADHERIN;

ADENOCARCINOMA; ADULT; CASE REPORT; FATALITY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; NOTE; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOLOGY; PEDIGREE; PRIMARY PREVENTION; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGE OF ONSET; CADHERINS; DNA MUTATIONAL ANALYSIS; FATAL OUTCOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; PEDIGREE; PRIMARY PREVENTION; STOMACH NEOPLASMS;

EID: 0036836184     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200211000-00001     Document Type: Note

References (55)

1. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:73-85.
2. Vleminckx K, Vakaet L Jr, Mareel M, et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-119. (Pubitemid 121001351)
3. Van Aken E, De Wever O, Correia-da-Rocha AS, et al. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 2001;439:725-751. (Pubitemid 33141317)
4. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene. Trends Biochem Sci 1999;24:73-76. (Pubitemid 29346577)
5. Shafiuddin M, Caminker M, Batra S. Hereditary linitis plastica of the stomach. Am J Gastroenterol 1995;90:2062-2063.
6. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-405. (Pubitemid 28168738)
7. Gayther SA, Goringe KL, Ramus SJ, et al. Identification of germline E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998;58:4086-4089. (Pubitemid 28440561)
8. Richards FM, McKee SA, Rajpar MH, et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 1999;8:607-610. (Pubitemid 29139974)
9. Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999;14:249-255. (Pubitemid 29407266)
10. Keller G, Vogelsang H, Becker I, et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 1999;155:337-342. (Pubitemid 29370383)
11. Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001;344:1904-1909. (Pubitemid 32553359)
12. Palli D, Galli M, Caporaso NE, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomark Prev 1994;3:15-18. (Pubitemid 24172516)
13. Laurén P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
14. Carneiro F. Classification of gastric carcinomas. Curr Diag Pathol 1997;4:51-59. (Pubitemid 127819220)
15. Shinmura K, Kohno T, Takahashi M, et al. Familial gastric cancer: clinicopathologic characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 1999;20:1127-1131. (Pubitemid 29263762)
16. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999;36:873-880. (Pubitemid 30003842)
17. Dussaulx-Garin L, Blayau M, Pagenault M, et al. A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extradigestive dissemination. Eur J Gastroenterol Hepatol 2001;13:711-715. (Pubitemid 32547872)
18. Oliveira C, Bordin MC, Grehan N, et al. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 2002;19:510-517. (Pubitemid 34461624)
19. Humar B, Toro T, Graziano F, et al. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 2002;19:518-525. (Pubitemid 34461625)
20. Seruca R, Carneiro F, Castedo S, et al. Familial gastric polyposis revisited. Autosomal dominant inheritance confirmed. Cancer Genet Cytogenet 1991;53:97-100.
21. Carneiro F, David L, Seruca R, et al. Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family. Cancer 1993;72:323-329. (Pubitemid 23193434)
22. Oliveira C, Huntsman D, Gorringe KL, et al. Familial gastric polyposis and diffuse carcinoma: a new hereditary gastric cancer syndrome not linked to E-cadherin. Eur J Cancer Prev 1999;8:356.
23. Yoon KA, Ku JL, Yang HK, et al. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 1999;44:177-180.
24. Iida S, Akiyama Y, Ichikawa W, et al. Infrequent germ-line mutation of E-cadherin gene in Japanese familial gastric cancer kindred. Clin Cancer Res 1999;5:1445-1447. (Pubitemid 29282950)
25. Avizienyte E, Launonen V, Salovaara R, et al. E-cadherin is not frequently mutated in hereditary gastric cancer. J Med Genet 2001;38:49-52. (Pubitemid 32102324)
26. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000, 26:16-17.
27. Chun YS, Lindor NM, Smyrk TC, et al. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer 2001;92:181-187. (Pubitemid 32623055)
28. Solcia E, Fiocca R, Cornaggia M, et al. Precancerous lesions of the stomach. In: Dobrilla G, ed. Problems and Controversies in Gastroenterology. New York: Raven Press; 1985:241-248.
29. Becker KF, Atkinson MJ, Reich U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845-3852. (Pubitemid 24241205)
30. Berx G, Becker KF, Hofler H, et al. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998;12:226-237. (Pubitemid 28418891)
31. Machado JC, Soares P, Carneiro F, et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 1999;79:459-465. (Pubitemid 29190435)
32. Tamura G, Yin J, Wang S, et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000;92:569-573. (Pubitemid 30212319)
33. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001;20:1525-1528. (Pubitemid 32291203)
34. Chan JK, Wong CS. Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast. Adv Anat Pathol 2001;8:165-172.
35. El-Bahrawy MA, Poulsom R, Jeffery R, et al. The expression of E-cadherin and catenins in sporadic colorectal carcinoma. Hum Pathol 2001;32:1216-1224. (Pubitemid 33104433)
36. Kallakury BV, Sheehan CE, Winn-Deen E, et al. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. Cancer 2001;92:2786-2795. (Pubitemid 33091915)
37. Schumacher C, Becker I, Oswald S, et al. Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations. Virchows Arch 1999;434:489-495. (Pubitemid 29281305)
38. Braungart E, Schumacher C, Hartmann E, et al. Functional loss of E-cadherin and cadherin-11 alleles on chromosome 16q22 in colonic cancer. J Pathol 1999;187:530-534. (Pubitemid 29151993)
39. Soares P, Berx G, van Roy F, et al. E-cadherin gene alterations are rare events in thyroid tumors. Int J Cancer 1997;70:32-38. (Pubitemid 27059702)
40. Rocha AS, Soares P, Seruca R, et al. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol 2001;194:358-366. (Pubitemid 32624563)
41. Ramires M, David L, Leitao D, et al. Ki67 labeling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas. J Pathol 1997;182:62-67. (Pubitemid 27240450)
42. Castro P, Sansonetty F, Soares P, et al. Fetal adenomas and minimally invasive follicular carcinomas of the thyroid frequently display a triploid or near triploid DNA pattern. Virchows Archiv 2001;438:336-342. (Pubitemid 32285357)
43. Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001;3:289-293. (Pubitemid 32851157)
44. Yonemasu H, Takashima M, Nishiyama KI, et al. Phenotypical characteristics of undifferentiated carcinoma of the pancreas: a comparison with pancreatic ductal adenocarcinoma and relevance of E-cadherin, alpha catenin and beta catenin expression. Oncol Rep 2001;8:745-752.
45. Liu D, Huang C, Kameyama K, et al. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg 2001;71:949-955.
46. Carico E, Atlante M, Bucci B, et al. E-cadherin and alpha-catenin expression during tumor progression of cervical carcinoma. Gynecol Oncol 2001;80:156-161. (Pubitemid 32158452)
47. Machado JC, Carneiro F, Beck S, et al. E-Cadherin expression is correlated with the isolated cell/diffuse histotype and with features of biological aggressiveness of gastric carcinoma. Int J Surg Pathol 1998;6:135-144. (Pubitemid 28357194)
48. Carneiro F, Seixas M, Sobrinho-Simoes M. New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 1995;191:571-584.
49. Amado M, Carneiro F, Seixas M, et al. Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 1998;114:462-470. (Pubitemid 28141191)
50. Mori M, Sakaguchi H, Akazawa K, et al. Correlation between metastatic site, histologic type, and serum tumor markers of gastric carcinoma. Hum Pathol 1995;26:504-508.
51. Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 2002;117:143-150. (Pubitemid 34052484)
52. Caldas C, Huntsman D. Reply to: Hereditary diffuse gastric cancer: more answers or more questions? Gastroenterology 2002;122:831-832.
53. Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001;93:1633-1637. (Pubitemid 33094870)
54. Lallier M, St-Vil D, Giroux M, et al. Related articles prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN2 syndrome. J Pediatr Surg 1998;33:846-848. (Pubitemid 28280809)
55. King JE, Dozois RR, Lindor NM, Ahlquist DA. Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc 2000;75:57-67. (Pubitemid 30035794)